These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3734138)

  • 1. Pharmacokinetics: dose-dependent changes.
    Browne TR; Greenblatt DJ; Evans JE; Szabo GK; Evans BA; Schumacher GE
    J Clin Pharmacol; 1986; 26(6):463-8. PubMed ID: 3734138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies with stable isotopes III: Pharmacokinetics of tracer doses of drug.
    Browne TR; Greenblatt DJ; Harmatz JS; Evans JE; Szabo GK; Evans BA; Schumacher GE
    J Clin Pharmacol; 1985; 25(1):59-63. PubMed ID: 3973065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staggered stable isotope administration technique for study of drug distribution.
    Evans JE; Browne TR; Kasdon DL; Szabo GK; Evans BA; Greenblatt DJ
    J Clin Pharmacol; 1985; 25(4):309-12. PubMed ID: 4008678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic drug monitoring. Pharmacokinetics.
    Taylor WJ
    Am J Med Technol; 1983 Aug; 49(8):557-63. PubMed ID: 6670671
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies with stable isotopes I: Changes in phenytoin pharmacokinetics and biotransformation during monotherapy.
    Browne TR; Evans JE; Szabo GK; Evans BA; Greenblatt DJ; Schumacher GE
    J Clin Pharmacol; 1985; 25(1):43-50. PubMed ID: 3973063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of changes in drug elimination in children.
    Prandota J
    Dev Pharmacol Ther; 1985; 8(5):311-28. PubMed ID: 3899553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic aspects of drug metabolism.
    Gibaldi M
    Ann N Y Acad Sci; 1971 Jul; 179():19-31. PubMed ID: 4936775
    [No Abstract]   [Full Text] [Related]  

  • 8. An introduction to pharmacokinetics.
    Ogilvie RI
    J Chronic Dis; 1983; 36(1):121-7. PubMed ID: 6848543
    [No Abstract]   [Full Text] [Related]  

  • 9. Dose-dependence of the apparent half-life of phenytoin in the rat.
    Vicuna A; Lalka D; duSouich P; Vicuna N; Ludden TM; McLean AJ
    Res Commun Chem Pathol Pharmacol; 1980 Apr; 28(1):3-11. PubMed ID: 7394315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug therapy for seizures.
    Wilder BJ
    Clin Ther; 1985; 7(2):246-53. PubMed ID: 3986864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination half-life of drugs: value and limitations.
    Greenblatt DJ
    Annu Rev Med; 1985; 36():421-7. PubMed ID: 3994325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of enzyme induction and enzyme inhibition.
    Park BK; Breckenridge AM
    Clin Pharmacokinet; 1981; 6(1):1-24. PubMed ID: 6113907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Some fundamental concepts of pharmacokinetic practice].
    Perrier CV; Griessen M
    Pharm Acta Helv; 1974; 49(7-8):217-28. PubMed ID: 4462123
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics of antiepileptic drugs.
    Browne TR
    Neurology; 1998 Nov; 51(5 Suppl 4):S2-7. PubMed ID: 9818917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of anticonvulsants.
    Hvidberg EF; Dam M
    Clin Pharmacokinet; 1976; 1(3):161-88. PubMed ID: 797496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some considerations as to the determination and significance of biologic half-life.
    Gibaldi M; Weintraub H
    J Pharm Sci; 1971 Apr; 60(4):624-6. PubMed ID: 5128379
    [No Abstract]   [Full Text] [Related]  

  • 17. Individual differences in the disposition of drugs metabolised in the body.
    Alvan G
    Clin Pharmacokinet; 1978; 3(2):155-75. PubMed ID: 346288
    [No Abstract]   [Full Text] [Related]  

  • 18. Interindividual differences in drug oxidation: clinical importance.
    Sjöqvist F; von Bahr C
    Drug Metab Dispos; 1973; 1(1):469-82. PubMed ID: 4149420
    [No Abstract]   [Full Text] [Related]  

  • 19. Phenobarbital does not alter phenytoin steady-state serum concentration or pharmacokinetics.
    Browne TR; Szabo GK; Evans J; Evans BA; Greenblatt DJ; Mikati MA
    Neurology; 1988 Apr; 38(4):639-42. PubMed ID: 3352926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetic basis of therapeutics with special reference to drugs used in neurology.
    Ebadi M
    Adv Neurol; 1975; 13():333-80. PubMed ID: 3106
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.